My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 134

    1.

    Effect of PlA1/A2 glycoprotein IIIa gene polymorphism on the long-term outcome after successful coronary stenting.

    Le Hello C, Morello R, Lequerrec A, Duarte C, Riddell J, Hamon M.

    Thromb J. 2007 Nov 16;5:19.PMID: 18021403 [PubMed - in process]Related articlesFree article

    2.

    PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement.

    Kastrati A, Koch W, Gawaz M, Mehilli J, Böttiger C, Schömig K, von Beckerath N, Schömig A.

    J Am Coll Cardiol. 2000 Jul;36(1):84-9.PMID: 10898417 [PubMed - indexed for MEDLINE]Related articles

    3.

    Prospective evaluation of the effect of an angiotensin I converting enzyme gene polymorphism on the long term risk of major adverse cardiac events after percutaneous coronary intervention.

    Hamon M, Fradin S, Denizet A, Filippi-Codaccioni E, Grollier G, Morello R.

    Heart. 2003 Mar;89(3):321-5.PMID: 12591842 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The effect of glycoprotein IIIa A1/A2 gene polymorphism on one-year outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

    Kozieradzka A, Kamiński KA, Pepiński W, Janica J, Korecki J, Skolimowski K, Frankowska E, Kralisz P, Bonda TA, Dobrzycki S, Musiał WJ.

    Kardiol Pol. 2006 Dec;64(12):1350-5; discussion 1356. English, Polish. PMID: 17206538 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement.

    Kastrati A, Schömig A, Seyfarth M, Koch W, Elezi S, Böttiger C, Mehilli J, Schömig K, von Beckerath N.

    Circulation. 1999 Mar 2;99(8):1005-10.PMID: 10051292 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Clinical outcome of patients with diabetes presenting with ST-elevation myocardial infarction and treated with concomitant use of glycoprotein IIb/IIIa inhibitors.

    Kralev S, Krause B, Papavassiliu T, Lang S, Haghi D, Kälsch T, Dempfle CE, Borggrefe M, Süselbeck T.

    Cardiol J. 2009;16(3):234-40.PMID: 19437397 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Reduced inhibition by abciximab in platelets with the PlA2 polymorphism.

    Wheeler GL, Braden GA, Bray PF, Marciniak SJ, Mascelli MA, Sane DC.

    Am Heart J. 2002 Jan;143(1):76-82.PMID: 11773915 [PubMed - indexed for MEDLINE]Related articles

    8.

    Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.

    Brugaletta S, Burzotta F, Trani C, Todaro D, Talarico G, Porto I, Leone AM, Niccoli G, Mazzari MA, Mongiardo R, Schiavoni G, Crea F.

    Minerva Cardioangiol. 2008 Feb;56(1):35-42.PMID: 18432167 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smoking.

    Lopes NH, Pereira AC, Hueb W, Soares PR, Lanz JR, Gersh BJ, de Oliveira S, Cesar LA, Ramires JF, Krieger JE.

    Am J Cardiol. 2004 Jun 15;93(12):1469-72.PMID: 15194015 [PubMed - indexed for MEDLINE]Related articles

    10.

    A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study.

    Laule M, Cascorbi I, Stangl V, Bielecke C, Wernecke KD, Mrozikiewicz PM, Felix SB, Roots I, Baumann G, Stangl K.

    Lancet. 1999 Feb 27;353(9154):708-12.PMID: 10073513 [PubMed - indexed for MEDLINE]Related articles

    11.

    Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention.

    Feldman DN, Wong SC, Bergman G, Minutello RM.

    J Invasive Cardiol. 2009 Jun;21(6):258-63.PMID: 19494400 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The PlA polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation.

    Boudoulas KD, Cooke GE, Roos CM, Bray PF, Goldschmidt-Clermont PJ.

    Arch Pathol Lab Med. 2001 Jan;125(1):112-5.PMID: 11151063 [PubMed - indexed for MEDLINE]Related articles

    13.

    Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

    Shen J, Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Zheng AF, Zhang X, Shen WF.

    Coron Artery Dis. 2008 Jun;19(4):271-7.PMID: 18480672 [PubMed - indexed for MEDLINE]Related articles

    14.

    Survival benefit with concomitant clopidogrel and glycoprotein IIb/IIIa inhibitor therapy at ad hoc percutaneous coronary intervention.

    Gumina RJ, Yang EH, Sandhu GS, Prasad A, Bresnahan JF, Lennon RJ, Rihal CS, Holmes DR Jr, Singh M.

    Mayo Clin Proc. 2008 Sep;83(9):995-1001.PMID: 18775199 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The PlA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with deep venous thrombosis.

    Renner W, Winkler M, Hoffmann C, Köppel H, Seinost G, Brodmann M, Pilger E.

    Int Angiol. 2001 Jun;20(2):148-51.PMID: 11533523 [PubMed - indexed for MEDLINE]Related articles

    16.

    Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome.

    Uretsky BF, Birnbaum Y, Osman A, Gupta R, Paniagua O, Chamoun A, Pohwani A, Lui C, Lev E, McGehee T, Kumar D, Akhtar A, Anzuini A, Schwarz ER, Wang FW.

    Catheter Cardiovasc Interv. 2008 Oct 1;72(4):488-97.PMID: 18814223 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Is PLA1/A2 gene polymorphism of platelet membrane glycoprotein IIIa a risk factor for myocardial infarct?]

    Melus V, Pullmann R, Hybenova J, Skerenova M, Pullmann R Jr.

    Bratisl Lek Listy. 1999 Nov;100(11):593-7. Slovak. PMID: 10758736 [PubMed - indexed for MEDLINE]Related articles

    18.

    The GPIIIa (beta3 integrin) PlA polymorphism in the early development of coronary atherosclerosis.

    Mikkelsson J, Perola M, Penttilä A, Goldschmidt-Clermont PJ, Karhunen PJ.

    Atherosclerosis. 2001 Feb 15;154(3):721-7.PMID: 11257275 [PubMed - indexed for MEDLINE]Related articles

    19.

    Platelet glycoprotein IIb/IIIa polymorphism and coronary artery disease: implications for clinical practice.

    Di Castelnuovo A, de Gaetano G, Benedetta Donati M, Iacoviello L.

    Am J Pharmacogenomics. 2005;5(2):93-9. Review.PMID: 15813672 [PubMed - indexed for MEDLINE]Related articles

    20.

    Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the Pl(A2)allele of the platelet glycoprotein IIIa gene.

    Walter DH, Schächinger V, Elsner M, Mach S, Dimmeler S, Auch-Schwelk W, Zeiher AM.

    Eur Heart J. 2001 Apr;22(7):587-95.PMID: 11259146 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk